Respiratory syncytial virus infection activates IL-13–producing group 2 innate lymphoid cells through thymic stromal lymphopoietin

BACKGROUND: Respiratory syncytial virus (RSV) is a major health care burden with a particularly high worldwide morbidity and mortality rate among infants. Data suggest that severe RSV-associated illness is in part caused by immunopathology associated with a robust type 2 response. OBJECTIVE: We soug...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Allergy Clin Immunol
Main Authors: Stier, Matthew T., Bloodworth, Melissa H., Toki, Shinji, Newcomb, Dawn C., Goleniewska, Kasia, Boyd, Kelli L., Quitalig, Marc, Hotard, Anne L., Moore, Martin L., Hartert, Tina V., Zhou, Baohua, McKenzie, Andrew N., Peebles, R. Stokes
Formato: Artigo
Idioma:Inglês
Publicado em: Mosby 2016
Assuntos:
Immune Deficiencies, Infection, and Systemic Immune Disorders
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5014571/
https://ncbi.nlm.nih.gov/pubmed/27156176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2016.01.050
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados